BR0017041A - Emprego de quimioterápicos - Google Patents

Emprego de quimioterápicos

Info

Publication number
BR0017041A
BR0017041A BR0017041-0A BR0017041A BR0017041A BR 0017041 A BR0017041 A BR 0017041A BR 0017041 A BR0017041 A BR 0017041A BR 0017041 A BR0017041 A BR 0017041A
Authority
BR
Brazil
Prior art keywords
halo
alkyl
optionally substituted
optionally
quinolizine
Prior art date
Application number
BR0017041-0A
Other languages
English (en)
Inventor
Hans-Herrmann Schulz
Guenther Schlimbach
Original Assignee
Hans-Herrmann Schulz
Guenther Schlimbach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7934136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0017041(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hans-Herrmann Schulz, Guenther Schlimbach filed Critical Hans-Herrmann Schulz
Publication of BR0017041A publication Critical patent/BR0017041A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A61K6/54—Filling; Sealing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

"EMPREGO DE QUIMIOTERáPICOS". A presente invenção refere-se ao emprego de quimioterápicos para a preparação de um medicamento para o tratamento tópico e/ou local de doenças provocadas por bactérias e/ou para a profilaxia no homem ou no animal.
BR0017041-0A 1999-12-22 2000-12-22 Emprego de quimioterápicos BR0017041A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19962470A DE19962470A1 (de) 1999-12-22 1999-12-22 Verwendung von Chemotherapeutika
PCT/EP2000/013155 WO2001045679A2 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung

Publications (1)

Publication Number Publication Date
BR0017041A true BR0017041A (pt) 2002-10-22

Family

ID=7934136

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0017041-0A BR0017041A (pt) 1999-12-22 2000-12-22 Emprego de quimioterápicos

Country Status (21)

Country Link
US (5) US8975275B2 (pt)
EP (2) EP1408034B2 (pt)
JP (1) JP5414138B2 (pt)
KR (1) KR100803442B1 (pt)
CN (2) CN101513405B (pt)
AT (2) ATE369344T1 (pt)
AU (1) AU784496B2 (pt)
BR (1) BR0017041A (pt)
CA (2) CA2717246C (pt)
CY (1) CY1106977T1 (pt)
DE (3) DE19962470A1 (pt)
DK (2) DK1408034T4 (pt)
ES (2) ES2218264T3 (pt)
IL (2) IL150359A0 (pt)
MX (1) MXPA02006248A (pt)
NO (2) NO323727B1 (pt)
PL (2) PL209943B1 (pt)
PT (2) PT1408034E (pt)
TR (1) TR200401396T4 (pt)
WO (1) WO2001045679A2 (pt)
ZA (1) ZA200205027B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6740664B2 (en) 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
CA2512199A1 (en) * 2002-12-31 2004-07-15 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drug
AU2003302305A1 (en) * 2002-12-31 2004-07-22 Sachin S Bhagwat Benzoquinolizine-2-carboxylic acid-containing compositions
NZ541681A (en) 2003-02-10 2009-02-28 Bayer Healthcare Ag Treatment of bacterial diseases of the respiratory organs by locally applying ciprofloxacin and its salts
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
PT1666477E (pt) * 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
US20050158376A1 (en) * 2003-10-23 2005-07-21 Sardi William F. Dietary supplement and method of processing same
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
WO2006134431A1 (en) * 2005-05-03 2006-12-21 Ranbaxy Laboratories Limited Formate salt of gemifloxacin
WO2007025187A2 (en) * 2005-08-26 2007-03-01 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
DE102005045145A1 (de) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
WO2008048289A2 (en) 2005-11-14 2008-04-24 University Of Maryland Biotechnology Institute Off. Of Research Admin./Tech. Dev. Salmonella based oral vaccines for anthrax
DE102006029500A1 (de) * 2006-06-27 2008-01-03 Schulz, Hans H. Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin
DE102007040569A1 (de) 2007-08-28 2009-03-05 Schulz, Hans H. Verfahren zur Prophylaxe von Karies und Parodontopathien
DE102008022086A1 (de) 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat
EP2409702A1 (en) * 2010-07-21 2012-01-25 Bayer Innovation GmbH Combination of siloxane and active ingredient for treating dental disorder of hard tissues
US8916528B2 (en) 2011-11-16 2014-12-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) * 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN106163526B (zh) 2014-01-29 2021-07-23 维奥姆治疗有限公司 抗性痤疮的治疗
EP3137011A4 (en) * 2014-04-29 2018-01-03 Dentsply International Inc. Endodontic treatment with long term drug delivery system
WO2018148455A1 (en) * 2017-02-08 2018-08-16 HKL Medical, LLC Intrasite administration and dosing methods and pharmaceuticals for use therein
SG11201911826VA (en) * 2017-06-16 2020-01-30 Kyorin Pharmaceutical Co Ltd Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
WO2019136022A1 (en) * 2018-01-02 2019-07-11 New York University Periodontal disease therapy
CN114008031A (zh) * 2019-10-23 2022-02-01 太景生物科技股份有限公司 喹诺酮羧酸衍生物

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387647A1 (fr) * 1977-04-20 1978-11-17 Spad Lab Pate de traitement endodontique pour l'obturation canalaire de dents
EP0035073B1 (de) * 1980-02-28 1984-06-13 BBC Aktiengesellschaft Brown, Boveri & Cie. Ventil mit einer Einrichtung zur Dämpfung von durch das Arbeitsmedium selbsterregten akustischen Schwingungen
NO156828C (no) 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
DE3635453A1 (de) 1986-08-07 1988-02-11 Hoechst Ag Antibakterielle klebefolie
JPS6343668A (ja) 1986-08-07 1988-02-24 ヘキスト・アクチエンゲゼルシヤフト 抗細菌接着フイルムおよびその製造方法
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
JP2558107B2 (ja) 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
DE3881939T2 (de) * 1987-02-26 1993-09-30 Rohto Pharma Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne.
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH0737385B2 (ja) 1989-01-18 1995-04-26 大塚製薬株式会社 外用抗菌剤
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5114718A (en) 1990-09-20 1992-05-19 The Procter & Gamble Company Sustained release compositions for treating periodontol disease
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
TW209865B (pt) 1992-01-10 1993-07-21 Bayer Ag
JP2913241B2 (ja) 1993-01-29 1999-06-28 富山化学工業株式会社 徐放性口腔用軟膏
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
IL122296A0 (en) * 1995-06-06 1998-04-05 Abbott Lab Quinolizinone type compounds
IT1280428B1 (it) * 1995-07-14 1998-01-20 R R A S R L Composizione farmaceutica per uso topico
CN1116905C (zh) * 1995-09-14 2003-08-06 高景曦 喹诺酮杀菌消炎止血纱布
CN1155382A (zh) * 1995-11-29 1997-07-30 董重里 广谱杀菌消毒剂
ES2319699T3 (es) 1996-05-20 2009-05-11 Otsuka Pharmaceutical Co., Ltd. Remedio para la rosacea.
JP3378772B2 (ja) 1997-06-23 2003-02-17 松下電工株式会社 コンクリート製円筒管の製造方法
KR100219327B1 (ko) 1997-08-09 1999-09-01 이서봉 퀴놀론 카르복실산 유도체
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
DE19814133A1 (de) * 1998-03-30 1999-10-07 Espe Dental Ag Selbstdesinfizierende Kunststoffe und ihre Verwendung im dentalen und dentaltechnischen Bereich
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
JP2002525326A (ja) * 1998-09-30 2002-08-13 アルコン ラボラトリーズ，インコーポレイテッド 眼、耳および鼻治療用の抗生物質組成物
CN1072498C (zh) * 1998-11-12 2001-10-10 毛和平 一种治疗人体烧伤、烫伤的外用药
CN1072499C (zh) * 1998-12-28 2001-10-10 毛和平 一种治疗人体体表慢性溃疡的外用药
US6262071B1 (en) * 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10347090A1 (de) * 2003-10-10 2005-05-04 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
EP1563731A1 (en) * 2004-02-12 2005-08-17 Bayer CropScience S.A. Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the ergosterol biosynthesis
JP5271229B2 (ja) 2009-10-05 2013-08-21 大道産業株式会社 濾過システム

Also Published As

Publication number Publication date
NO323727B1 (no) 2007-07-02
CN101513405B (zh) 2012-07-04
NO331317B1 (no) 2011-11-21
NO20023026L (no) 2002-08-20
DE50005742D1 (de) 2004-04-22
DK1408034T3 (da) 2007-12-17
CY1106977T1 (el) 2012-09-26
EP1408034B1 (de) 2007-08-08
ES2291583T3 (es) 2008-03-01
ZA200205027B (en) 2004-03-08
US20160045490A1 (en) 2016-02-18
ATE369344T1 (de) 2007-08-15
KR100803442B1 (ko) 2008-02-13
PT1244434E (pt) 2004-08-31
ES2291583T5 (es) 2011-09-29
AU2171601A (en) 2001-07-03
KR20020063257A (ko) 2002-08-01
NO20071958L (no) 2002-08-20
CN100488950C (zh) 2009-05-20
DK1244434T3 (da) 2004-07-19
AU784496B2 (en) 2006-04-13
JP2004501063A (ja) 2004-01-15
IL150359A (en) 2007-12-03
DK1408034T4 (da) 2011-08-15
IL150359A0 (en) 2002-12-01
CN1668598A (zh) 2005-09-14
US20030045544A1 (en) 2003-03-06
EP1408034A1 (de) 2004-04-14
DE19962470A1 (de) 2001-07-12
NO20023026D0 (no) 2002-06-21
US20070197501A1 (en) 2007-08-23
PT1408034E (pt) 2007-11-15
PL205148B1 (pl) 2010-03-31
TR200401396T4 (tr) 2004-08-23
US20100330165A1 (en) 2010-12-30
US20140287028A1 (en) 2014-09-25
PL209943B1 (pl) 2011-11-30
MXPA02006248A (es) 2002-12-05
JP5414138B2 (ja) 2014-02-12
US8975275B2 (en) 2015-03-10
EP1244434A2 (de) 2002-10-02
CN101513405A (zh) 2009-08-26
WO2001045679A3 (de) 2002-07-18
DE50014553D1 (de) 2007-09-20
ATE261722T1 (de) 2004-04-15
EP1244434B1 (de) 2004-03-17
CA2395459C (en) 2011-11-01
WO2001045679A2 (de) 2001-06-28
CA2717246C (en) 2014-02-11
ES2218264T3 (es) 2004-11-16
CA2717246A1 (en) 2001-06-28
EP1408034B2 (de) 2011-05-25
PL357379A1 (en) 2004-07-26
CA2395459A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
NO20071958L (no) Anvendelse av kjemoterapi midler
CA2121230A1 (en) 1,3-dihydro-2h-imidazo(4,5-b) quinolin-2-one derivatives
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
JPS62185085A (ja) 眼科用薬剤
ATE186301T1 (de) An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one
ATE113043T1 (de) 7-(3-(aminomethyl)-3-alkyl-1- pyrrolidinyl>chinolin-3-carbonsäure-derivate und diese enthaltende pharmazeutische zusammensetzungen.
JPH01316321A (ja) ギラーゼ抑制因子の筋肉注射剤
NO160995C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bis -(4-aminofenyl)-sulfoner.
PT947513E (pt) Derivados de amina triciclicos
KR970703147A (ko) 동맥경화 억제제(Arteriosclerosis Depressant)
BR0204489A (pt) Derivados de rodamina, composto, intermediários, processos para a sìntese de derivados de rodamina, uso de um composto, métodos para a terapia fotodinâmica de pacientes, para purga in vitro da medula óssea humana, para o tratamento de leucemias, de distúrbios imunológicos e de infecções geradas por bactérias e para prevenção de doença, composição farmacêutica fotoativável, composição e solução bactericida e medicamento.
JPH06166623A (ja) 抗菌性組成物
KR910015543A (ko) 7-(치환된) 시클로알킬아미노-1-(치환된)-6-플루오로-1,4-디히드로-4-옥소-3-퀴놀린카르복실산 및 그의 염, 그의 제조방법, 그를 포함한 항균 조성물 및 그를 사용한 치료방법
NL7510483A (en) Alpha-ureido-thienylacetamido-cephalosporanic acids - with broad-spectrum antibacterial activity for oral or parenteral admin., for disinfection and as additives for animal feeds

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25G Requested change of headquarter approved

Owner name: HANS-HERRMANN SCHULZ (DE) , GUENTHER SCHLIMBACH (D

Free format text: ENDERECO DO 1O E 2O DEPOSITANTES ALTERADOS CONFORME SOLICITADO NA PETICAO NO 020110100701/RJ DE 28/09/2011.

B25A Requested transfer of rights approved

Owner name: BAYER INNOVATION GMBH (DE)

Free format text: TRANSFERIDO DE: HANS-HERRMANN SCHULZ E GUENTHER SCHLIMBACH